Why Is EPO Low in Polycythemia Vera? What It Means

In polycythemia vera (PV), the bone marrow makes red blood cells because of abnormal internal signaling, so the kidneys turn erythropoietin (EPO) production down; therefore, a low EPO level is a response to the overproduction, not the driver of it. It can be confusing to see a low EPO level on your lab report when your body is producing too many red blood cells, but in PV, a result below the laboratory reference range is actually the expected response.

To understand why, it helps to look at how your body normally controls red blood cell production and how PV disrupts this process.

The Normal “Thermostat” for Red Blood Cells

Normally, your body controls red blood cell production using a negative feedback loop, much like how a thermostat controls a heater ^[1].

• The Sensors (Kidneys): Your kidneys constantly monitor the amount of oxygen available in their local tissues ^[2].
• The Signal (EPO): If oxygen levels are low, the kidneys produce a hormone called erythropoietin (EPO) ^[2].
• The Factory (Bone Marrow): EPO travels to your bone marrow and acts as a signal to turn on the “factory,” telling it to produce more red blood cells ^[3].
• The Shut-Off: Once enough red blood cells are made and oxygen levels improve, the kidneys sense this and reduce EPO production, turning the factory’s signal off ^[2].

The Broken Switch in Polycythemia Vera

In polycythemia vera, this system is disrupted by an acquired genetic change, most commonly a JAK2 mutation (such as the JAK2 V617F or exon 12 variants) ^[3].

The JAK2 mutation acts like a broken switch in the bone marrow’s red blood cell factory. Instead of waiting for the EPO signal from the kidneys, the mutated cells are stuck in the “on” position ^[4]. They multiply and overproduce red blood cells independently of the body’s normal regulatory mechanisms ^[3].

Note: PV can also cause an overproduction of white blood cells and platelets, although the EPO feedback loop is mainly relevant to the red blood cells ^[4].

The Body’s Response to Thick Blood

As your bone marrow pumps out excessive numbers of red blood cells, your blood becomes crowded and thicker. The increased red-cell mass generally raises your blood’s oxygen-carrying capacity and suppresses renal EPO production, but the thicker blood can also slow blood flow ^[1].

Your kidneys sense this adequate oxygen supply. Following their normal programming, they turn down EPO production in an attempt to tell the bone marrow to stop making more cells ^[1]. However, because of the JAK2 mutation, the bone marrow ignores this lack of EPO and continues to overproduce red blood cells ^[4][3].

Therefore, a low EPO level means your kidneys are responding correctly to the high red blood cell count ^[1]. It does not mean your kidneys are failing, and you should never take EPO or related treatments to try and raise your levels unless specifically instructed by your specialist.

How EPO Levels are Used in Diagnosis

Because this pattern is so characteristic of the disease, a low or “subnormal” EPO level (meaning it is below the reference range used by your specific laboratory) is considered a “minor criterion” in formal diagnostic guidelines ^[5][6]. This means it is one supporting piece of evidence, but it cannot diagnose PV on its own ^[5].

A formal diagnosis requires a combination of factors, such as sustained high red blood cell counts, specific bone marrow findings, and genetic testing. A JAK2 mutation test is a key part of the diagnostic evaluation ^[5][6][7]. Rare primary erythrocytoses can also produce low EPO, so your doctor will evaluate your results carefully to rule out other causes ^[8]. Your doctor will interpret your EPO level alongside your complete blood count (CBC) patterns, symptoms, and other test results ^[9].

It is also worth noting that a normal EPO level does not entirely rule out PV ^[10]. Some patients with confirmed PV still have EPO levels that fall within the normal range ^[10].

What a Low EPO Result Does Not Tell You

• It is not a measure of PV severity: A lower EPO number does not mean your PV is “worse.”
• It does not replace routine monitoring: Your doctor will still track your hemoglobin and hematocrit to guide treatment.
• It does not predict clot risk: Your symptom management and blood clot risk are evaluated separately from your EPO levels.

Important Safety Note: Because the thicker blood in PV increases the risk of blood clots, you should seek urgent medical care if you experience possible clot symptoms, such as sudden weakness or numbness, trouble speaking, chest pain, shortness of breath, or a painful, swollen leg.